Wuhan’s Humanwell seeks $150m loan amid Covid-19

hubei px230
By Rashmi Kumar
19 Mar 2020

Humanwell Healthcare Group Co, a pharmaceuticals company based in the epicentre of the Covid-19 pandemic, has launched a $150m loan into general syndication.

The Chinese company is headquartered in Wuhan, where the coronavirus outbreak originated. While its fundraising plans have been in the works for the past few weeks, they were put on the back burner temporarily while the capital city of the Hubei province worked at containing the virus, which ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.